Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,21The interpretation and reporting of the data presented here are the responsibility of the authors, and in no way should be seen as an official policy or interpretation of the United States government.2See Editorial by Orth and Uehlinger, p. 1580.
- 1 April 2003
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 63 (4), 1462-1467
- https://doi.org/10.1046/j.1523-1755.2003.00860.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Smoking and the KidneyJournal of the American Society of Nephrology, 2002
- Prevalence and Clinical Correlates of Coronary Artery Disease among New Dialysis Patients in the United StatesJournal of the American Society of Nephrology, 2001
- Relationship of dose of hemodialysis and cause-specific mortalityKidney International, 1996
- Sex and Time Trends in Cardiovascular Disease Incidence and Mortality: the Framingham Heart Study, 1950-1989American Journal of Epidemiology, 1996
- The Human Costs of Tobacco UseThe New England Journal of Medicine, 1994
- The Human Costs of Tobacco UseThe New England Journal of Medicine, 1994
- The health risks of smoking the framingham study: 34 years of follow-upAnnals of Epidemiology, 1993
- Hemodynamic Effects of Smoking in Congestive Heart FailureThe American Journal of the Medical Sciences, 1988
- Dialysis-associated ischemic heart disease: Insights from coronary angiographyKidney International, 1984
- Disabling angina pectoris with normal coronary arteries in patients undergoing long-term hemodialysisAmerican Journal Of Medicine, 1981